DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Debrisoquine
Debrisoquine
Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy with Hospitalization for Upper Gastrointestinal Tract Bleeding
Comparison of Debrisoquine and Guanethidine In
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy with Hospitalization for Upper Gastrointestinal Tract Bleeding
Debrisoquine Sulphate -A New Antihypertensive Agent with Minimal Side -Effects
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
Comprehensive Pharmacogenetic Genotyping Panel 6
Stereospecific Pharmacokinetics and Pharmacodynamics of Beta- Adrenergic Blockers in Humans
Stembook 2018.Pdf
Absorption of Drugs, 14-15 Elderly And, 320-321 Abstinence Syndrome In
Medication Use, Falls and Genetic Variants in an Older Population
Index Vol. 16-23
Council of Europe Committee of Ministers (Partial
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
The Hitchhiker's Guide to Clinical Pharmacology
Screening for Hypertension in Children and Adolescents to Prevent Cardiovascular Disease: Systematic Review for the U.S
Factors Predisposing to Postural Hypotensive Symptoms in the Treatment of High Blood Pressure
Anatomical Classification Guidelines V2017
Top View
Polymorphic Hydroxylation of Debrisoquine in Man A
Essential Medicines in the United States Andrew Ellner
POISONS LIST APPENDIX Amoebicides
Harmonized Tariff Schedule of the United States (2006) (Rev
Therapeutic and Toxic Blood Concentrations of More Than 1100 Drugs and Other Xenobiotics
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
Genetic Susceptibility to Adverse Drug Reactions: a Clinical Expression of Deficient Drug Oxidation Phenotype
Pharmaceutical Appendix to the Tariff Schedule 2
Adrenergic Blockers in Regard to Their Stereochemistry
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Rg02: Drugs Reference Guide
Pharmaceuticals Appendix
L:\0900\0900PHARMAPPX .Wpd
Resolution Ap (2000) 1
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
The Biochemical and Clinical Pharmacology of These Agents Is Evident